Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
ELEPSIA XR (LEVETIRACETAM) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
ELEPSIA XR
NDA
Get alerts
LEVETIRACETAM | N204417 | TRIPOINT THERAPEUTICS
2 strengths
5 unique patents
0 unique exclusivities
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
DMF
Approvals
Label
Products
Patent Timeline
5 unique patents by expiration date
All strengths
1GM
1.5GM
Expired (2)
Active (3)
Today
2027
Today
8163306
Sep. 3, 2027
8425938
Feb. 22, 2026
8431156
Oct. 31, 2027
8470367
Oct. 31, 2027
8535717
Feb. 22, 2026
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (2)
Sort:
Name
↑
Applicant
Strength
Approval
#001 — 1GM
RLD
5 patents
0 exclusivities
▴
TABLET, EXTENDED RELEASE;ORAL | Approved: Dec 20, 2018
Patents (5)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
8163306
Sep 3, 2027
—
—
Yes
—
—
8425938
Feb 22, 2026
—
—
Yes
—
—
8431156
Oct 31, 2027
—
—
Yes
—
—
8470367
Oct 31, 2027
—
—
Yes
—
—
8535717
Feb 22, 2026
—
—
Yes
—
—
#002 — 1.5GM
RLD
5 patents
0 exclusivities
▾
TABLET, EXTENDED RELEASE;ORAL | Approved: Dec 20, 2018